IOC

The gene expression of Leishmania infantum chagasi inside Lutzomyia longipalpis, the main vector of visceral leishmaniasis in Brazil

Plasmodium vivax metacaspase 1 (PvMCA1) catalytic domain is conserved in field isolates from Brazilian Amazon

Urban infestation by Triatoma infestans (Hemiptera: Reduviidae), an overlooked phenomena for Chagas disease in Argentina

Reemergence of human malaria in Atlantic Forest of Rio Grande do Sul, Brazil

COVID-19 diagnosis by RT-qPCR in alternative specimens

The promising drugs included in WHO’s Solidarity Project: a choice based in scientific knowledge and institutional competencies

A new Trypanosoma cruzi genotyping method enables high resolution evolutionary analyses

Transcriptome comparison of dengue-susceptible and -resistant field derived strains of Colombian Aedes aegypti using RNA-sequencing

Population structure and ancestry prediction of Aedes aegypti (Diptera: Culicidae) supports a single African origin of Colombian populations

Presence of trypanosomatids, with emphasis on Leishmania, in Rodentia and Didelphimorphia mammals of a rural settlement in the central Amazon region

Characterising four Sarconesiopsis magellanica (Diptera: Calliphoridae) larval fat body-derived antimicrobial peptides

Comparison of viral load between saliva and nasopharyngeal swabs for SARS-CoV2: the role of days of symptoms onset on diagnosis

Evaluation of cytochrome b sequence to identify Leishmania species and variants: the case of Panama

Differential expression profiles of miRNAs and their putative targets in Schistosoma mansoni during its life cycle

Geographical origin of chronic Chagas disease patients in Brazil impacts the performance of commercial tests for anti-T. cruzi IgG

Flight tone characterisation of the South American malaria vector Anopheles darlingi (Diptera: Culicidae)

Gene expression of Paracoccidioides virulence factors after interaction with macrophages and fibroblasts

Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells

Transmission-blocking compound candidates against Plasmodium vivax using P. berghei as an initial screening

Inhibition of nitric oxide production of activated mice peritoneal macrophages is independent of the Toxoplasma gondii strain

Validation of ELISA with recombinant antigens in serological diagnosis of canine Leishmania infantum infection

Genomics and functional genomics in Leishmania and Trypanosoma cruzi: statuses, challenges and perspectives

Do the new triatomine species pose new challenges or strategies for monitoring Chagas disease? An overview from 1979-2021

An emerging paradigm for the origin and evolution of shelled amoebae, integrating advances from molecular phylogenetics, morphology and paleontology

Mechanism of action of glycyrrhizin against Plasmodium falciparum

The adaptation of SARS-CoV-2 to humans

Expansion of T regulatory lymphocytes by murine bone marrow dendritic cells previously stimulated with Anisakis simplex larval antigens

Subregional initiatives for Chagas disease. A path of technical cooperation, opened by the countries, as an approach to a neglected disease

Chagas disease and mobility: comments on the challenges for access and the right to health for migrants

The achievement of a storytelling about Chagas disease: how to talk about silence; how to visualise the invisible

A glimmer of hope for a neglected disease - How Chagas disease associative movement is driving progress towards disease control and elimination

Stronger control-surveillance systems for vector-borne Chagas disease

Systematic review on the biology, ecology, genetic diversity and parasite transmission potential of Panstrongylus geniculatus (Latreille 1811) in Latin America

Molecular epidemiology of Mycobacterium tuberculosis in Brazil before the whole genome sequencing era: a literature review

Comment on “The translational challenge in Chagas disease drug development” by Kratz et al.

Air in the tires: towards an achievable, efficacious and timely diagnosis for Chagas disease

Revisiting Chagas' disease diagnostic strategies in light of different scenarios of Trypanosoma cruzi infection

How is global change affecting Chagas disease landscapes?

Chagas disease (American trypanosomiasis) in the context of the 2030 agenda. Insights into global warming and vector control

Reflections how IEC can empower and integrate stakeholders to denormalise Chagas disease and drive care and prevention policy: healthcare system governance at the heart of Chagas disease neglect

Reflections, suggestions for putting into practice the principles of information, education and communication - IEC on Chagas disease in a community context

Pathophysiology and new targets for therapeutic options in Chagas heart disease

The challenge of risk assessment in the riddle of Chagas heart disease

Traditional use of benznidazole with weekly clinical follow-up indicate to be an important approach for the etiologic treatment of Chagas disease

Chagas disease challenge - New techniques for diagnosis and treatment address to control in endemic areas

Chagas disease and its historicity

A note on the the discovery of Chagas' disease

Reflections on Chagas disease in the Amazon

Challenges for fighting Chagas disease in the 21st century

Chagas disease treatment: a 120-year-old challenge to public health

Inscrever-se em IOC